Charles River Laboratories International (CRL) Short Interest Ratio & Short Volume $187.74 -9.16 (-4.65%) (As of 11/15/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Charles River Laboratories International Short Interest DataCharles River Laboratories International (CRL) has a short interest of 1.85 million shares. This marks a -12.32% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.6, indicating that it would take 2.6 days of the average trading volume of 624,577 shares to cover all short positions.Current Short Interest1,850,000 sharesPrevious Short Interest2,110,000 sharesChange Vs. Previous Month-12.32%Dollar Volume Sold Short$330.37 millionShort Interest Ratio2.6 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares51,140,000 sharesPercentage of Shares Shorted3.62%Today's Trading Volume1,499,025 sharesAverage Trading Volume624,577 sharesToday's Volume Vs. Average240% Short Selling Charles River Laboratories International? Sign up to receive the latest short interest report for Charles River Laboratories International and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCRL Short Interest Over TimeCRL Days to Cover Over TimeCRL Percentage of Float Shorted Over Time Ad Weiss RatingsThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”Click here to find out more about what could be Trump and JD Vance’s favorite coin. Charles River Laboratories International Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20241,850,000 shares $330.37 million -12.3%N/A2.6 $178.58 10/15/20242,110,000 shares $409.00 million +7.1%N/A2.8 $193.84 9/30/20241,970,000 shares $388.03 million +4.2%N/A2.7 $196.97 9/15/20241,890,000 shares $375.37 million +29.5%N/A2.8 $198.61 8/31/20241,460,000 shares $288.72 million -7.6%N/A2.3 $197.75 8/15/20241,580,000 shares $319.51 million -14.1%N/A2.5 $202.22 Get the Latest News and Ratings for CRL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Charles River Laboratories International and its competitors with MarketBeat's FREE daily newsletter. 7/31/20241,840,000 shares $449.36 million +1.1%N/A2.9 $244.22 7/15/20241,820,000 shares $393.58 million +1.1%N/A3.6 $216.25 6/30/20241,800,000 shares $371.84 million -3.2%N/A3.5 $206.58 6/15/20241,860,000 shares $389.61 million -12.7%N/A3.6 $209.47 5/31/20242,130,000 shares $444.19 million +22.4%N/A4.1 $208.54 5/15/20241,740,000 shares $404.65 million -8.4%N/A3.4 $232.56 4/30/20241,900,000 shares $435.10 million -0.5%N/A3.6 $229.00 4/15/20241,910,000 shares $450.63 million +20.9%N/A3.6 $235.93 3/31/20241,580,000 shares $428.10 million -0.6%N/A2.8 $270.95 3/15/20241,590,000 shares $411.76 million -9.1%N/A2.9 $258.97 2/29/20241,750,000 shares $444.83 million -8.9%N/A3.1 $254.19 2/15/20241,920,000 shares $471.30 million +14.3%3.8%3.6 $245.47 1/31/20241,680,000 shares $363.20 million +27.3%N/A3.2 $216.19 1/15/20241,320,000 shares $279.17 million -12.0%N/A2.4 $211.49 12/31/20231,500,000 shares $354.60 million -8.5%N/A2.9 $236.40 12/15/20231,640,000 shares $378.53 million +11.6%N/A3.2 $230.81 11/30/20231,470,000 shares $289.71 million -9.8%N/A2.8 $197.08 11/15/20231,630,000 shares $305.74 million -3.0%N/A3.1 $187.57 10/31/20231,680,000 shares $282.84 million -4.0%N/A3.3 $168.36 10/15/20231,750,000 shares $334.29 million +4.8%N/A3.8 $191.02 9/30/20231,670,000 shares $327.29 million -1.8%N/A3.6 $195.98 9/15/20231,700,000 shares $353.40 million +10.4%N/A3.5 $207.88 8/31/20231,540,000 shares $318.50 million +11.6%N/A3.4 $206.82 8/15/20231,380,000 shares $289.90 million +9.5%N/A2.9 $210.07 7/31/20231,260,000 shares $264.02 million -3.8%2.5%2.5 $209.54 7/15/20231,310,000 shares $271.90 million -9.0%2.6%2.5 $207.56 6/30/20231,440,000 shares $302.76 million -5.9%2.9%2.8 $210.25 6/15/20231,530,000 shares $319.75 million +11.7%3.1%2.9 $208.99 5/31/20231,370,000 shares $264.96 million +2.2%2.7%2.5 $193.40 5/15/20231,340,000 shares $257.76 million -13.0%2.7%2.2 $192.36 4/30/20231,540,000 shares $292.78 million +11.6%N/A2.7 $190.12 4/15/20231,380,000 shares $281.09 million +2.2%2.8%2.5 $203.69 3/31/20231,350,000 shares $272.46 million +3.9%2.7%2.4 $201.82 3/15/20231,300,000 shares $253.37 million -0.8%2.6%2.3 $194.90Unveiled: NVIDIA’s "Secret Royalty" Program (Ad)Did you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?Click Here to learn how to get in now >>> 2/28/20231,310,000 shares $287.34 million +11.0%2.6%2.3 $219.34 2/15/20231,180,000 shares $296.81 million +3.5%2.4%2 $251.53 1/31/20231,140,000 shares $277.31 million +11.8%2.3%1.9 $243.25 1/15/20231,020,000 shares $237.27 million +1.0%N/A1.6 $232.62 12/30/20221,010,000 shares $220.08 million -2.9%N/A1.7 $217.90 12/15/20221,040,000 shares $227.24 million +17.6%N/A1.6 $218.50 11/30/2022884,200 shares $202.10 million -8.4%N/A1.4 $228.57 11/15/2022965,300 shares $241.39 million -19.6%N/A1.6 $250.07 10/31/20221,200,000 shares $254.70 million -8.4%N/A2 $212.25 10/15/20221,310,000 shares $258.36 million +14.9%N/A2.2 $197.22 9/30/20221,140,000 shares $224.35 million -12.3%N/A2 $196.80 9/15/20221,300,000 shares $264.69 million +28.7%N/A2.4 $203.61 8/31/20221,010,000 shares $207.30 million -1.9%N/A1.9 $205.25 8/15/20221,030,000 shares $238.85 million +5.4%N/A2 $231.89 7/31/2022976,900 shares $244.75 million -7.0%1.9%1.9 $250.54 7/15/20221,050,000 shares $230.74 million -0.9%2.2%2 $219.75 6/30/20221,060,000 shares $226.81 million +2.9%2.2%1.9 $213.97 6/15/20221,030,000 shares $219.28 million +4.7%2.2%1.9 $212.89 5/31/2022983,800 shares $230.29 million -8.1%N/A1.8 $234.08 5/15/20221,070,000 shares $252.32 million -0.9%N/A1.9 $235.81 4/30/20221,080,000 shares $260.83 million +3.9%2.2%1.8 $241.51 4/15/20221,040,000 shares $296.02 million +7.7%2.1%2 $284.63 3/31/2022965,900 shares $274.29 million -8.9%1.9%1.8 $283.97 3/15/20221,060,000 shares $274.78 million -11.7%2.1%2.1 $259.23 2/28/20221,200,000 shares $349.39 million +11.1%2.4%2.5 $291.16 2/15/20221,080,000 shares $337.64 million +68.0%2.2%2.5 $312.63 1/31/2022642,900 shares $212.00 million +2.3%1.3%1.7 $329.76 1/15/2022628,700 shares $223.19 million -9.0%1.3%1.6 $355.01 12/31/2021690,900 shares $260.32 million +5.3%1.4%1.8 $376.78 12/15/2021656,000 shares $238.08 million -8.4%1.3%1.8 $362.92 11/30/2021716,400 shares $262.11 million -11.7%1.4%1.8 $365.87 11/15/2021811,200 shares $311.94 million +37.9%1.6%2.1 $384.54 10/29/2021588,100 shares $263.87 million -9.8%1.2%1.6 $448.68 10/15/2021651,700 shares $262.99 million +3.4%1.3%2 $403.54 9/30/2021630,300 shares $260.11 million +13.5%1.3%1.9 $412.67 9/15/2021555,400 shares $244.26 million -8.2%1.1%1.8 $439.79 8/31/2021605,200 shares $268.62 million +6.5%1.2%2.1 $443.86 8/13/2021568,500 shares $233.78 million -2.7%1.2%1.6 $411.22 7/30/2021584,400 shares $237.80 million -9.4%1.2%1 $406.92 7/15/2021644,800 shares $246.41 million -14.2%1.3%1.1 $382.15 6/30/2021751,900 shares $278.14 million -5.6%1.5%1.2 $369.92 6/15/2021796,600 shares $282.28 million -2.8%1.6%1.3 $354.36 5/28/2021819,800 shares $277.08 million +29.6%1.7%1.4 $337.99 5/14/2021632,500 shares $203.04 million +2.4%N/A1.2 $321.01 4/30/2021617,600 shares $206.20 million +2.9%N/A1.8 $333.87 4/15/2021600,000 shares $185.50 million -8.7%N/A1.9 $309.17 3/31/2021657,200 shares $189.25 million -3.6%N/A2.1 $287.96 3/15/2021682,000 shares $195.59 million -5.8%N/A2.2 $286.79 2/26/2021724,000 shares $202.85 million +9.6%N/A2.3 $280.18 2/12/2021660,900 shares $191.17 million +19.1%N/A2.2 $289.25The Tesla Trade Is Back In Business (Ad)If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.Discover how to trade Tesla, simply follow this link here. 1/29/2021554,800 shares $144.74 million -16.2%N/A1.9 $260.88 1/15/2021662,200 shares $176.75 million -3.8%N/A2.2 $266.91 12/31/2020688,600 shares $171.18 million +9.7%N/A2.2 $248.59 12/15/2020627,600 shares $150.67 million +6.8%N/A2 $240.07 11/30/2020587,800 shares $135.29 million -19.7%N/A1.8 $230.16 11/15/2020731,900 shares $174.93 million +5.6%N/A2.2 $239.01 10/30/2020692,900 shares $158.63 million +9.5%N/A2.1 $228.94 10/15/2020632,600 shares $154.76 million +1.5%N/A2 $244.64 9/30/2020623,400 shares $141.17 million +3.7%N/A1.9 $226.45 9/15/2020601,400 shares $135.50 million -3.2%N/A1.7 $225.30 8/31/2020621,400 shares $136.06 million -31.2%N/A1.8 $218.95 8/14/2020903,500 shares $193.79 million +17.2%N/A2.4 $214.49 7/31/2020770,800 shares $153.38 million -10.6%N/A2 $198.99 7/15/2020861,800 shares $166.72 million -16.3%1.8%2.3 $193.45 6/30/20201,030,000 shares $174.07 million -17.6%2.1%2.7 $169.00 6/15/20201,250,000 shares $224.68 million +5.9%2.6%3.1 $179.74 5/29/20201,180,000 shares $207.83 million +7.3%2.4%2.5 $176.13 5/15/20201,100,000 shares $179.30 million +21.1%2.3%2.3 $163.00 4/30/2020908,400 shares $131.42 million -15.9%1.9%1.8 $144.67 4/15/20201,080,000 shares $150.58 million +30.0%2.2%2.2 $139.43 3/31/2020831,000 shares $113.81 million -0.4%1.7%1.7 $136.95 3/13/2020834,100 shares $115.91 million -17.4%1.7%2.2 $138.96 2/28/20201,010,000 shares $101.51 million +7.5%2.1%2.7 $100.50 2/14/2020939,300 shares $138.39 million +1.7%2.0%2.8 $147.33 1/31/2020923,300 shares $148.70 million -10.4%1.9%3 $161.05 1/15/20201,030,000 shares $178.52 million +5.4%2.1%3.3 $173.32 12/31/2019976,900 shares $151.71 million -7.8%2.0%3.2 $155.30 CRL Short Interest - Frequently Asked Questions What is Charles River Laboratories International's current short interest? Short interest is the volume of Charles River Laboratories International shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 1,850,000 shares of CRL short. Learn More on Charles River Laboratories International's current short interest. What is a good short interest ratio for Charles River Laboratories International? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRL shares currently have a short interest ratio of 3.0. Learn More on Charles River Laboratories International's short interest ratio. Which institutional investors are shorting Charles River Laboratories International? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Charles River Laboratories International: Jane Street Group LLC, Wolverine Trading LLC, Parallax Volatility Advisers L.P., Walleye Trading LLC, Walleye Capital LLC, PEAK6 Investments LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Charles River Laboratories International's short interest increasing or decreasing? Charles River Laboratories International saw a decrease in short interest during the month of October. As of October 31st, there was short interest totaling 1,850,000 shares, a decrease of 12.3% from the previous total of 2,110,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Charles River Laboratories International's short interest compare to its competitors? Here is how the short interest of companies compare to Charles River Laboratories International: Agilent Technologies, Inc. (1.21%), Mettler-Toledo International Inc. (1.34%), Illumina, Inc. (4.24%), Waters Co. (3.63%), Bio-Techne Co. (2.00%), Bio-Rad Laboratories, Inc. (3.40%), Bruker Co. (3.70%), Pacific Biosciences of California, Inc. (18.41%), Harvard Bioscience, Inc. (0.91%), Thermo Fisher Scientific Inc. (0.77%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Charles River Laboratories International stock? Short selling CRL is an investing strategy that aims to generate trading profit from Charles River Laboratories International as its price is falling. CRL shares are trading down $9.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Charles River Laboratories International? A short squeeze for Charles River Laboratories International occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CRL, which in turn drives the price of the stock up even further. How often is Charles River Laboratories International's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRL, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies A Short Squeeze MTD Short Squeeze ILMN Short Squeeze WAT Short Squeeze TECH Short Squeeze BIO Short Squeeze BRKR Short Squeeze PACB Short Squeeze HBIO Short Squeeze TMO Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:CRL) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.